BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27832543)

  • 1. Using an Inducible CRISPR-dCas9-KRAB Effector System to Dissect Transcriptional Regulation in Human Embryonic Stem Cells.
    Parsi KM; Hennessy E; Kearns N; Maehr R
    Methods Mol Biol; 2017; 1507():221-233. PubMed ID: 27832543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
    Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
    Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells.
    Pham H; Kearns NA; Maehr R
    Methods Mol Biol; 2016; 1358():43-57. PubMed ID: 26463376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
    Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
    Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of sgRNA as a Major Factor Affecting CRISPRi Knockdown Efficiency in K562 Cells].
    Wang Y; Xie Y; Dong ZC; Jiang XJ; Gong P; Lu J; Wan F
    Mol Biol (Mosk); 2021; 55(1):86-95. PubMed ID: 33566028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
    Lowder LG; Paul JW; Qi Y
    Methods Mol Biol; 2017; 1629():167-184. PubMed ID: 28623586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient KRAB domain for CRISPRi applications in human cells.
    Alerasool N; Segal D; Lee H; Taipale M
    Nat Methods; 2020 Nov; 17(11):1093-1096. PubMed ID: 33020655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.
    Olson A; Basukala B; Lee S; Gagne M; Wong WW; Henderson AJ
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33053801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/dCas9 Switch Systems for Temporal Transcriptional Control.
    Gjaltema RAF; Schulz EG
    Methods Mol Biol; 2018; 1767():167-185. PubMed ID: 29524134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
    Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a human embryonic stem cell line, WAe009-A-99, with constitutive expression of the dCas9-p300 fusion protein.
    Kang EH; Kim JW; Noh H; Park SH; Park HJ; Yoon S; Kim H
    Stem Cell Res; 2023 Feb; 66():102986. PubMed ID: 36493708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Gene Silencing in Leptospira biflexa by RNA-Guided Catalytically Inactive Cas9 (dCas9).
    Fernandes LGV; Nascimento ALTO
    Methods Mol Biol; 2020; 2134():109-122. PubMed ID: 32632863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene repression via multiplex gRNA strategy in Y. lipolytica.
    Zhang JL; Peng YZ; Liu D; Liu H; Cao YX; Li BZ; Li C; Yuan YJ
    Microb Cell Fact; 2018 Apr; 17(1):62. PubMed ID: 29678175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
    Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
    Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression.
    Yang Y; Mei H; Han X; Zhang X; Cheng J; Zhang Z; Wang H; Xu H
    Cell Mol Biol Lett; 2023 Nov; 28(1):96. PubMed ID: 38017385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
    Li R; Xia X; Wang X; Sun X; Dai Z; Huo D; Zheng H; Xiong H; He A; Wu X
    PLoS Biol; 2020 Nov; 18(11):e3000749. PubMed ID: 33253175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus.
    Peng R; Wang Y; Feng WW; Yue XJ; Chen JH; Hu XZ; Li ZF; Sheng DH; Zhang YM; Li YZ
    Microb Cell Fact; 2018 Jan; 17(1):15. PubMed ID: 29378572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling transcription in human pluripotent stem cells using CRISPR-effectors.
    Genga RM; Kearns NA; Maehr R
    Methods; 2016 May; 101():36-42. PubMed ID: 26525193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.